Mr. Speaker, I would like to take this opportunity to thank my colleague for his important question. It also allows me an opportunity to reiterate our government's commitment to making sure that all Canadians have access to a national pharmacare program, and that work is well under way.
I would like to remind this House that in budget 2019 we received a funding commitment of $35 million to ensure the creation of a Canadian drug agency, which is the foundational piece for a national pharmacare program. We have also received $1 billion to address the area of rare diseases.
I look forward to working with provinces, territories, indigenous groups and others to make sure that all Canadians will have access to a pharmacare program.